Skip to main content

. 1984 Feb;49(2):245–246. doi: 10.1038/bjc.1984.38

A chlorambucil-anti-CEA conjugate cytotoxic for human colon adenocarcinoma cells in vitro.

L G Bernier, M Page, R C Gaudreault, L P Joly

PMCID: PMC1976705 PMID: 6696825

245

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Belles-Isles M., Pagé M. Anti-oncofoetal proteins for targeting cytotoxic drugs. Int J Immunopharmacol. 1981;3(1):97–102. doi: 10.1016/0192-0561(81)90049-7. [DOI] [PubMed] [Google Scholar]
Blakeslee D., Chen M., Kennedy J. C. Aggregation of chlorambucil in vitro may cause misinterpretation of protein binding data. Br J Cancer. 1975 Jun;31(6):689–692. doi: 10.1038/bjc.1975.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
Blakeslee D., Kennedy J. C. Factors affecting the noncovalent binding of chlorambucil to rabbit immunoglobulin G. Cancer Res. 1974 Apr;34(4):882–885. [PubMed] [Google Scholar]
GOLD P., FREEDMAN S. O. DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES. J Exp Med. 1965 Mar 1;121:439–462. doi: 10.1084/jem.121.3.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
Guclu A., Ghose T., Tai J., Mammen M. Binding of chlorambucil with antitumor globulins and its effect on drug and antibody activities. Eur J Cancer. 1976 Feb;12(2):95–100. doi: 10.1016/0014-2964(76)90211-5. [DOI] [PubMed] [Google Scholar]
Tai J., Blair A. H., Ghose T. Tumor inhibition by chlorambucil covalently linked to antitumor globulin. Eur J Cancer. 1979 Nov;15(11):1357–1363. doi: 10.1016/0014-2964(79)90112-9. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES